Insulin aspart efficacy and safety compared to buffered regular insulin (Velosulin®) and insulin lispro for continuous subcutaneous insulin infusion

被引：0
|
作者：
Bode, B
Weinstein, R
Bell, D
McGill, J
Nadeau, D
Raskin, P
Davidson, J
Kim, D
Reinhardt, R
机构：
来源：
DIABETES | 2001年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A106 / A106
页数：1
相关论文
共 50 条
  • [1] Insulin aspart efficacy and safety compared to buffered regular insulin (Velosulin®) for continuous subcutaneous insulin infusion
    Bode, B
    McCulloch, K
    Strange, P
    DIABETES, 2000, 49 : A98 - A98
  • [2] Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion - A randomized study in type 1 diabetes
    Bode, B
    Raskin, P
    Weinstein, R
    Davidson, J
    Bell, D
    Henry, R
    McGill, J
    Huang, WC
    Nadeau, D
    Reinhardt, RR
    DIABETES CARE, 2002, 25 (03) : 439 - 444
  • [3] Efficacy and safety of insulin aspart compared to buffered human insulin by continuous sc insulin infusion.
    Bode, B
    DIABETOLOGIA, 2000, 43 : A200 - A200
  • [4] A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump
    Raskin, P
    Holcombe, JH
    Tamborlane, WV
    Malone, JI
    Strowig, S
    Ahern, JA
    Lavent, F
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (06) : 295 - 300
  • [5] Safety of insulin glulisine compared with insulin aspart administered by continuous subcutaneous insulin infusion (CSII)
    Hanaire-Broutin, H
    Schumicki, DM
    Hoogma, RPL
    Souhami, E
    DIABETOLOGIA, 2004, 47 : A298 - A298
  • [6] Safety of insulin glulisine compared with insulin aspart administered by continuous subcutaneous insulin infusion (CSII)
    Hanaire-Broutin, H
    Schumicki, DM
    Hoogma, RPLM
    Souhami, E
    DIABETES, 2004, 53 : A4 - A4
  • [7] EFFICACY AND SAFETY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION OF FASTER ASPART COMPARED WITH INSULIN ASPART IN TYPE 1 DIABETES
    Klonoff, D.
    Evans, M.
    Lane, W.
    Kempe, H. P.
    Renard, E.
    DeVries, H.
    Graungaard, T.
    Hyseni, A.
    Battelino, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A32 - A33
  • [8] Insulin aspart for continuous subcutaneous insulin infusion
    Barrio Castellanos, Raquel
    Martin Frias, Maria
    AVANCES EN DIABETOLOGIA, 2012, 28 : 10 - 14
  • [9] Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial
    van Bon, Arianne C.
    Bode, Bruce W.
    Sert-Langeron, Caroline
    DeVries, J. Hans
    Charpentier, Guillaume
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (06) : 607 - 614
  • [10] In vitro stability of insulin lispro in continuous subcutaneous insulin infusion
    DeFelippis, Michael R.
    Bell, Maureen A.
    Heyob, Jennifer A.
    Storms, Sacha M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2006, 8 (03) : 358 - 368
12345